These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 19837123)

  • 1. Interindividual variations in the efficacy and toxicity of vaccines.
    Thomas C; Moridani M
    Toxicology; 2010 Dec; 278(2):204-10. PubMed ID: 19837123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
    Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
    Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics in the evaluation of efficacy and adverse events during clinical development of vaccines.
    Nilsson LJ; Regnström KJ
    Methods Mol Biol; 2008; 448():469-79. PubMed ID: 18370243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines.
    Deforest A; Long SS; Lischner HW; Girone JA; Clark JL; Srinivasan R; Maguire TG; Diamond SA; Schiller RP; Rothstein EP
    Pediatrics; 1988 Feb; 81(2):237-46. PubMed ID: 3340474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity in vaccine immune response: the role of immunogenetics and the emerging field of vaccinomics.
    Poland GA; Ovsyannikova IG; Jacobson RM; Smith DI
    Clin Pharmacol Ther; 2007 Dec; 82(6):653-64. PubMed ID: 17971814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine.
    Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D
    Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccinations and risk of central nervous system demyelinating diseases in adults.
    DeStefano F; Verstraeten T; Jackson LA; Okoro CA; Benson P; Black SB; Shinefield HR; Mullooly JP; Likosky W; Chen RT;
    Arch Neurol; 2003 Apr; 60(4):504-9. PubMed ID: 12707063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers.
    Englund JA; Walter EB; Gbadebo A; Monto AS; Zhu Y; Neuzil KM
    Pediatrics; 2006 Sep; 118(3):e579-85. PubMed ID: 16950949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics: role in medicines approval and clinical use.
    Novelli G; Borgiani P; Ciccacci C; Di Daniele N; Sirugo G; Papaluca Amati M
    Public Health Genomics; 2010; 13(5):284-91. PubMed ID: 19815999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variation in the response to vaccination.
    Kimman TG; Vandebriel RJ; Hoebee B
    Community Genet; 2007; 10(4):201-17. PubMed ID: 17895626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunizations for HIV-infected adults: indications, timing, and response.
    Spach DH
    Top HIV Med; 2006 Dec-2007 Jan; 14(5):154-8. PubMed ID: 17237556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
    Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
    J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles, mumps, and rubella vaccines.
    Wharton M; Cochi SL; Williams WW
    Infect Dis Clin North Am; 1990 Mar; 4(1):47-73. PubMed ID: 2407778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity in response to particulate antigen-delivery systems.
    Storni T; Kündig TM; Senti G; Johansen P
    Adv Drug Deliv Rev; 2005 Jan; 57(3):333-55. PubMed ID: 15560945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The iscom antigen-presenting system.
    Morein B
    Nature; 1988 Mar; 332(6161):287-8. PubMed ID: 3347272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged.
    Tang YC; Thoman M; Linton PJ; Deisseroth A
    Cancer Immunol Immunother; 2009 Dec; 58(12):1949-57. PubMed ID: 19444444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics in HIV therapy.
    Rodríguez-Nóvoa S; Barreiro P; Jiménez-Nacher I; Rendón A; Soriano V
    AIDS Rev; 2005; 7(2):103-12. PubMed ID: 16092504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles, mumps and rubella: control by vaccination.
    van Druten JA; de Boo T; Plantinga AD
    Dev Biol Stand; 1986; 65():53-63. PubMed ID: 3556777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.